Search - tctmd.com

Displaying 161 - 180 of 314

Sort: Relevancy | Date

Presentation TCT 2015

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? No, It Is Too Complex and There Is No Advantage for the Patient!

Presenter: William A. Gray, D. Christopher Metzger, Bernhard Reimers

October 14, 2015

Presentation TCT 2015

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? Yes, It Is a Game Changer for Both Outcomes and Adoption of Carotid Stenting!

Presenter: William A. Gray, D. Christopher Metzger, Christopher J. Kwolek

October 14, 2015

Presentation TCT 2015

Mesh-Covered Stents for Carotid Intervention: Rationale, Device Designs, Imaging, and Data to Date

Presenter: William A. Gray, D. Christopher Metzger, Piotr Musialek

October 14, 2015

Presentation TCT 2015

Update on the ACST-2 Trial: Early Outcomes and Perspectives on the Field From Across the Pond

Presenter: William A. Gray, D. Christopher Metzger, Bernhard Reimers

October 14, 2015

Presentation TCT 2015

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? Another Failed NIH-Funded Study: CREST-2 Is CORAL Redux (or Worse)!

Presenter: William A. Gray, D. Christopher Metzger

October 14, 2015

Presentation TCT 2015

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? The CREST-2 Trial Is the Right Trial at the Right Time!

Presenter: William A. Gray, D. Christopher Metzger, Gary S. Roubin

October 14, 2015

Presentation TCT 2015

What Are the Hard Data Regarding the Impact of Medical Therapy on Stroke Prevention in Established Severe Carotid Stenosis?

Presenter: William A. Gray, D. Christopher Metzger, Klaus D. Mathias

October 14, 2015

Presentation TCT 2015

Beyond Stenosis Severity: Top 5 Important Duplex Characteristics to Identify in the Patient With Carotid Disease

Presenter: William A. Gray, D. Christopher Metzger, Jan Sloves

October 14, 2015

Presentation TCT 2015

When and How to Treat a Claudicant With an Occluded SFA

Presenter: William A. Gray, Gregg W. Stone, D. Christopher Metzger, Herbert D. Aronow

October 14, 2015

Presentation TCT 2015

Stable CAD With Substantial Ischemia and No-to-Mild Symptoms: Initial Revascularization vs Medical Therapy

Presenter: William A. Gray, Gregg W. Stone, D. Christopher Metzger, Sripal Bangalore

October 14, 2015

Presentation TCT 2015

The ILLUMINATE RCT: One-Year Outcomes

Presenter: William A. Gray, Peter A. Schneider, Mahmood K. Razavi

October 12, 2015

Presentation TCT 2015

Extended Follow-up From LEVANT 2: Two-Year Follow-up and Subgroup Analyses

Presenter: William A. Gray, Peter A. Schneider, Andrej Schmidt

October 12, 2015

Presentation TCT 2015

IN.PACT SFA 1-year Outcomes: Subgroup Analyses

Presenter: William A. Gray, Peter A. Schneider, John R. Laird Jr

October 12, 2015

Presentation TCT 2015

Obtaining Pericardial Access for LAA Closure: Imaging and Tools

Presenter: Stefan C. Bertog, Josep Rodés-Cabau, William A. Gray

October 11, 2015

Presentation TCT 2015

Update on St. Judes Trial

Presenter: Farrell O. Mendelsohn, William B. White, William A. Gray

October 11, 2015

Presentation TCT 2015

Peering Through the Veil: Outcomes Reporting in SFA Intervention Decoded

Presenter: Gary M. Ansel, Michael R. Jaff, William A. Gray

October 11, 2015

Presentation TCT 2015

Debate: For SFA Disease I Prefer a Drug-Eluting Stent!

Presenter: Julie Logan, William A. Gray

October 11, 2015

News Industry News

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

September 30, 2015

News Daily News

目前无症状患者的颈动脉闭塞的卒中风险似乎极低

September 29, 2015

News Daily News

Stroke Risk of Carotid Occlusion Appears Very Low in Contemporary Asymptomatic Patients

September 29, 2015

Advertisement

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? No, It Is Too Complex and There Is No Advantage for the Patient!

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? Yes, It Is a Game Changer for Both Outcomes and Adoption of Carotid Stenting!

Mesh-Covered Stents for Carotid Intervention: Rationale, Device Designs, Imaging, and Data to Date

Update on the ACST-2 Trial: Early Outcomes and Perspectives on the Field From Across the Pond

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? Another Failed NIH-Funded Study: CREST-2 Is CORAL Redux (or Worse)!

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? The CREST-2 Trial Is the Right Trial at the Right Time!

What Are the Hard Data Regarding the Impact of Medical Therapy on Stroke Prevention in Established Severe Carotid Stenosis?

Beyond Stenosis Severity: Top 5 Important Duplex Characteristics to Identify in the Patient With Carotid Disease

When and How to Treat a Claudicant With an Occluded SFA

Stable CAD With Substantial Ischemia and No-to-Mild Symptoms: Initial Revascularization vs Medical Therapy

The ILLUMINATE RCT: One-Year Outcomes

Extended Follow-up From LEVANT 2: Two-Year Follow-up and Subgroup Analyses

IN.PACT SFA 1-year Outcomes: Subgroup Analyses

Obtaining Pericardial Access for LAA Closure: Imaging and Tools

Update on St. Judes Trial

Peering Through the Veil: Outcomes Reporting in SFA Intervention Decoded

Debate: For SFA Disease I Prefer a Drug-Eluting Stent!

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

目前无症状患者的颈动脉闭塞的卒中风险似乎极低

Stroke Risk of Carotid Occlusion Appears Very Low in Contemporary Asymptomatic Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content